News & Updates
DiaSys warmly invites you to attend the presentation of our immunoassay developer Thomas Masetto on "Challenges in the development of IVD kits for the measurement of sepsis markers: an IVD manufacturer point of view".
DiaSys is pleased to announce the launch of LDH 21 FS, a new assay for determination of Lactate Dehydrogenase (LDH).
Not only has the pandemic been the dominant issue for the last two years, but the recent floods in the Ahr valley (Rhineland-Palatinate) and neighboring areas have lately added another unexpected and life-threatening situation for many people.
DiaSys is pleased to announce the availability of LDL-c direct FS, a new homogenous assay for direct determination of LDL-cholesterol (LDL-C).
The state Rhineland-Palatinate awards the 2021 Innovation Prize in the category “cooperation“ to DiaSys Diagnostic Systems GmbH along with Hochschule Fresenius – University of Applied Sciences, for developing a new procalcitonin (PCT) test using PETIA technology.
The success story of the owner-managed company DiaSys Diagnostic Systems GmbH started in 1991 by introducing liquid-stable laboratory reagents to determine enzymes and substrates in clinical chemistry.
The amendment of the German Medical Devices Dispensing Ordinance now allows direct selling of COVID-19 antigen rapid tests to all German employers (acc. to Section 2, Par. 3 of the German Occupational Safety and Health Act). In this regard, DiaSys Deutschland Vertriebs-GmbH has issued a press release announcing the sale of rapid diagnostics.
We are pleased to announce a strategic partnership between DiaSys Diagnostic Systems GmbH and ROBERT RIELE GmbH & Co KG, Berlin, for the exclusive marketing of the “505” flow cell photometer.